Puma Biotech (PBYI)
10.90
+0.14 (1.30%)
Upcoming Events
Latest Headlines
Form SCHEDULE 13D/A PUMA BIOTECHNOLOGY, INC. Filed by: AUERBACH ALAN H
October 6, 2026 9:37 PM - SEC Filing
Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026 5:00 PM - BizWire
Puma Biotechnology starts phase II lung cancer trial with alisertib
September 17, 2026 4:07 PM - StreetInsider
Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
September 17, 2026 4:07 PM - BizWire
Form 4 PUMA BIOTECHNOLOGY, INC. For: Sep 14 Filed by: WILSON TROY EDWARD
September 16, 2026 9:14 PM - SEC Filing
Form 4 PUMA BIOTECHNOLOGY, INC. For: Sep 14 Filed by: Cesano Alessandra
September 16, 2026 9:06 PM - SEC Filing
Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: Cesano Alessandra
September 14, 2026 12:05 PM - SEC Filing
Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: WILSON TROY EDWARD
September 14, 2026 12:02 PM - SEC Filing
Puma Biotechnology (PBYI) PT Raised to $6 at TD Cowen
August 7, 2026 8:52 AM - StreetInsider
Puma Biotech (PBYI) Tops Q2 EPS by 16c
August 6, 2026 5:45 PM - StreetInsider
Form 10-Q PUMA BIOTECHNOLOGY, INC. For: Jun 30
August 6, 2026 4:44 PM - SEC Filing
Form 8-K PUMA BIOTECHNOLOGY, INC. For: Aug 06
August 6, 2026 4:28 PM - SEC Filing
Puma Biotechnology Reports Second Quarter 2026 Financial Results
August 6, 2026 4:05 PM - BizWire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
August 5, 2026 5:00 PM - BizWire
Full Article List
